(Q51302141)
Statements
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. (English)
1 reference
L Pacifico
1 reference
M Di Martino
1 reference
P Versacci
1 reference
G Andreoli
1 reference
L M Silvestri
1 reference
C Chiesa
1 reference
25 April 2015
1 reference
25
1 reference
8
1 reference
734-741
1 reference